ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 76 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $343,000 | -33.1% | 131,912 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $513,000 | +44.1% | 131,912 | -0.2% | 0.00% | – |
Q2 2016 | $356,000 | +1994.1% | 132,237 | +2239.6% | 0.00% | – |
Q1 2016 | $17,000 | -26.1% | 5,652 | -3.7% | 0.00% | – |
Q4 2015 | $23,000 | +35.3% | 5,867 | +3.3% | 0.00% | – |
Q3 2015 | $17,000 | -29.2% | 5,681 | 0.0% | 0.00% | – |
Q2 2015 | $24,000 | -91.5% | 5,681 | -92.3% | 0.00% | – |
Q1 2015 | $283,000 | -42.2% | 73,324 | +0.6% | 0.00% | -100.0% |
Q4 2014 | $490,000 | +21.3% | 72,861 | -1.0% | 0.00% | 0.0% |
Q3 2014 | $404,000 | -45.1% | 73,614 | +2.6% | 0.00% | 0.0% |
Q2 2014 | $736,000 | -4.7% | 71,758 | +11.6% | 0.00% | 0.0% |
Q1 2014 | $772,000 | +5.9% | 64,316 | -0.2% | 0.00% | 0.0% |
Q4 2013 | $729,000 | +3.6% | 64,436 | -1.4% | 0.00% | 0.0% |
Q3 2013 | $704,000 | +39.4% | 65,352 | +19.9% | 0.00% | 0.0% |
Q2 2013 | $505,000 | – | 54,525 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Values First Advisors, Inc. | 250,110 | $528,000 | 0.51% |
XTX MARKETS LLC | 12,925 | $27,000 | 0.19% |
Cornerstone Capital, Inc. | 491,560 | $1,037,000 | 0.15% |
Aristides Capital LLC | 64,482 | $136,000 | 0.10% |
LINCOLN CAPITAL CORP | 57,000 | $120,000 | 0.09% |
HighVista Strategies LLC | 41,400 | $87,000 | 0.07% |
Ahrens Investment Partners LLC | 61,500 | $130,000 | 0.05% |
J Arnold Wealth Management Co | 18,000 | $38,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 114,437 | $241,000 | 0.03% |
Avidian Wealth Solutions, LLC | 63,000 | $133,000 | 0.02% |